Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Theranexus Société Anonyme
  6. News
  7. All News
    ALTHX   FR0013286259

THERANEXUS SOCIÉTÉ ANONYME

(ALTHX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about THERANEXUS SOCIÉTÉ ANONYME
06/16THERANEXUS  : Minutes of the combined general meeting of 16 june 2021
AN
04/07THERANEXUS  : 2020 full-year results and update on the progress of main programs
PU
04/07THERANEXUS  : 2020 full-year results and update on the progress of main programs
AN
03/10THERANEXUS  : Extends the capacities of neurolead, its asset screening platform,..
AQ
03/09THERANEXUS  : Theranexus extends the capabilities of neurolead, its active agent..
AN
01/22THERANEXUS  : presents an update on the progress of its main programs and announ..
PU
01/19THERANEXUS  : Provides an update on the progress of its main programs and announ..
AQ
01/18THERANEXUS  : Theranexus presents an update on the progress of its main programs..
AN
2020THERANEXUS  : Publishes its 2021 financial agenda
AQ
2020THERANEXUS  : announces its financial calendar for 2021
PU
2020THERANEXUS  : Theranexus announces its financial calendar for 2021
AN
2020THERANEXUS THE  : Lyon neuroscience research center and CERMEP announce the crea..
AQ
2020THERANEXUS  : Creates Drug Development JV; Stock Down4%
MT
2020THERANEXUS  : Lyon Neuroscience Research Center and CERMEP announce the creation..
PU
2020THERANEXUS  : Theranexus, lyon neuroscience research center and cermep announce ..
AN
2020THERANEXUS  : - The Food And Drug Administration issues a favorable opinion on t..
AQ
2020THERANEXUS  : The Food And Drug Administration (FDA) issues a favorable opinion ..
PU
2020THERANEXUS  : The food and drug administration (fda) issues a favorable opinion ..
AN
2020THERANEXUS  : - Presentation of the results of the phase 1b clinical study with ..
AQ
2020THERANEXUS  : Presentation of the results of the phase 1b clinical study of THN2..
PU
2020THERANEXUS  : Presentation of the results of the phase ib clinical study of thn2..
AN
2020THERANEXUS  : TTHERANEXUS and the BBDF Foundation Obtain Orphan Drug Status in E..
AQ
2020THERANEXUS  : and BBDF obtain European "orphan medicinal product" designation fo..
PU
2020THERANEXUS  : publishes its cash position as of September 30, 2020
AQ
2020THERANEXUS  : announces its first half results
AQ
2020THERANEXUS  : takes stock of its scientific news
AQ
2020THERANEXUS  : Theranexus presents its latest scientific news
AN
2020THERANEXUS  : and BBDF Foundation Achieve Orphan Drug and Rare Pediatric Disease..
AQ
2020THERANEXUS  : Theranexus and bbdf obtain orphan drug designation (odd) and rare ..
AN
2020THERANEXUS  : Theranexus to present the results of thn102 for parkinson’s diseas..
AN
2020THERANEXUS  : HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT 1st HALF 2020
AQ
2020THERANEXUS  : Announces its cash position at june 30, 2020 and the establishment..
AQ
2020THERANEXUS  : Theranexus announces its cash position as of 30 june 2020 and impl..
AN
2020THERANEXUS  : obtains non-dilutive financing of EUR 3.4m in the form of a loan g..
AQ
2020THERANEXUS  : Theranexus secures eur 3.4 m loan under the french state guarantee..
AN
2020THERANEXUS  : - 2019 annual results and update on the progress of activities
AQ
2020THERANEXUS  : 2019 full-year results and update on activities
AN
2020THERANEXUS  : Announces Successful Phase 2 Study for THN102 in Parkinson's disea..
AQ
2020THERANEXUS  : Theranexus announces the success of its phase ii trial for thn102 ..
AN
2020THERANEXUS  : publishes its cash position as of December 31, 2019
AQ
2020THERANEXUS  : Theranexus reports cash position as of december 31, 2019
AN
2020THERANEXUS  : Publie son agenda financier 2020
AQ
2020THERANEXUS  : Theranexus announces its financial calendar for 2020
AN
2020THERANEXUS  : Announces the clinical results of its phase ib study demonstrating..
AQ
2020THERANEXUS  : Theranexus announces the clinical results of its phase ib study de..
AN
2019THERANEXUS  : Theranexus and Beyond Batten Disease Foundation (BBDF) announce th..
AN
2019THERANEXUS  : Theranexus reports cash position as of september 30, 2019
AN
2019THERANEXUS  : Theranexus announces its first half 2019 results
AN
2019THERANEXUS  : A new milestone reached for theranexus: inclusion of last patient ..
AN
2019THERANEXUS  : Theranexus announces inclusion of last subject in its phase ib tri..
AN
2019THERANEXUS  : Theranexus announces the publication of two scientific papers and ..
AN
2019THERANEXUS  : Theranexus raises approximately 2.2 million euros in a placement r..
AN
2019THERANEXUS  : Theranexus announces the launch of a capital increase by private p..
AN
2019THERANEXUS  : Theranexus reports cash position as of june 30, 2019
AN
2019THERANEXUS  : Theranexus and Beyond Batten Disease Foundation (BBDF) announce ag..
AN
2019THERANEXUS  : THERANEXUS INVITED TO JOIN IN THE HEALTHTECH INVESTOR DAYS (HTID) ..
AN
2019THERANEXUS  : Theranexus announces the formation of its scientific board
AN
2019THERANEXUS  : Theranexus to present new data on neuron-glia interactions at two ..
AN
2019THERANEXUS  : Theranexus announces issuance of chinese patent covering its drug ..
AN
2019THERANEXUS  : Theranexus provides 2018 full-year results and update on activitie..
AN
2019THERANEXUS  : Theranexus announces research collaboration with irisa* using arti..
AN
2019THERANEXUS  : Theranexus to present new scientific data on drug candidate thn201..
AN
2019THERANEXUS  : Theranexus announces preliminary results of phase ii trial of thn1..
AN
2019THERANEXUS  : Theranexus reports cash position as of 31 december 2018 and provid..
AN
2019THERANEXUS  : THERANEXUS set to receive EUR 6.2 million in funding from the Fren..
AN
2019THERANEXUS  : Theranexus announces its financial calendar for 2019
AN
2018THERANEXUS  : Theranexus announces appointment of jerome martinez to its board o..
AN
2018THERANEXUS  : Theranexus september 30th cash position and business update
AN
2018THERANEXUS  : Theranexus announces inclusion of last patient in phase ii trial o..
AN
2018THERANEXUS  : Theranexus plans to expand its phase ii pipeline with a third prog..
AN
2018THERANEXUS  : Theranexus announces that rodolphe besserve will join its board of..
AN
2018THERANEXUS  : Theranexus announces a new european patent protecting thn201, its ..
AN
2018THERANEXUS  : Recognition of the scientific excellence of theranexus
AN
2018THERANEXUS  : THERANEXUS ANNOUNCES ITS FIRST HALF 2018 RESULTS - CASH POSITION A..
AN
2018THERANEXUS  : THERANEXUS OBTAINS THE AUTHORIZATION TO START A PHASE Ib CLINICAL ..
AN
1  2Next